CLSA Research has come out with its earning estimates on the pharma sector for the quarter ended June' 07. According to the report Cipla net profit is seen down 17% at Rs 141.4 crore (Rs 1414 million) versus Rs 170.3 crore (Rs 1703 million) YoY. During the same quarters its net sales are seen up 10.5% at Rs 931.8 crore (Rs 9318 million) as against Rs 843 crore (Rs 8434 million) in the corresponding quarter previous year.